Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

LifeVantage Corp

LFVN ✓ COMPLIANT ☆ Track — members

NASDAQ · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: BUY

Last Close

$6.17

▼ -3.14%

Market Cap $77.29M · Vol 23.84K

Key Metrics

P/E Ratio

15.51

FWD: 18.43

Market Cap

$77.29M

Micro Cap

Div Yield

3.14%

Quarterly dividend

EPS Growth

-42.26%

YoY

RSI (14)

34.05

Momentum

Beta

0.69

vs Market

52W High

$11.72

47.35% below

52W Low

$3.91

57.80% above

Volume

23.84K

Avg 14.45K

P/B

2.33

Price-to-book

ROE

21.03%

Return on equity

Free Float

84.14%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, LifeVantage Corp (LFVN) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LFVN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.06%

-7.36%

-34.98%

+16.86%

YTD

+0.16%

-47.35%

-13.59%

-13.76%

Financials & Valuation

TTM · Annual

Total Revenue	$182.59M
Net Income	$5.07M
Revenue Growth (YoY)	-23.11%
Gross Margin	77.56%
Operating Margin	3.23%
Net Profit Margin	2.78%
ROE	21.03%
ROA · ROIC	9.05% · 14.87%

P/E Ratio	15.51
Forward P/E (FY1)	18.43
PEG Ratio	-0.33
P/S	0.43
P/B	2.33
P/FCF	11.88
EPS Growth	-42.26%
Outstanding Shares	12.53M

Technical Indicators

50-Day SMA	$6.41
200-Day SMA	$5.95
RSI (14)	34.05
Beta	0.69
52-Week High	$11.72
52-Week Low	$3.91

Volume Today	23.84K
Avg Daily Volume (30D)	14.45K
Relative Volume	1.65x
Volatility (10D)	29.65
Volatility (30D)	31.98
Free Float	84.14%

Analyst Consensus

BUY

Current Price $6.17

Mean Target $7.50

52W Low$3.91 52W High$11.72

Current

Target

$3.91 $11.72

Current Analyst target

+21.56% upside potential · 3 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG001S6TDX7

ISINUS53222K2050

CountryUSA

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 2, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Company -0.65% JNJ Johnson & Johnson -0.29% ABBV AbbVie Inc. +0.83% NVS Novartis AG -0.23% NOVN.S Novartis AG -0.09%

Company Profile

LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.